110 related articles for article (PubMed ID: 7561888)
41. Cerebral blood perfusion after treatment with zolpidem and flumazenil in the baboon.
Clauss RP; Dormehl IC; Kilian E; Louw WK; Nel WH; Oliver DW
Arzneimittelforschung; 2002; 52(10):740-4. PubMed ID: 12442636
[TBL] [Abstract][Full Text] [Related]
42. In vivo bidirectional modulatory effect of benzodiazepine receptor ligands on GABAergic transmission evaluated by positron emission tomography in non-human primates.
Brouillet E; Chavoix C; Bottlaender M; Khalili-Varasteh M; Hantraye P; Fournier D; Dodd RH; Mazière M
Brain Res; 1991 Aug; 557(1-2):167-76. PubMed ID: 1660750
[TBL] [Abstract][Full Text] [Related]
43. Zolpidem is a potent stoichiometry-selective modulator of α1β3 GABAA receptors: evidence of a novel benzodiazepine site in the α1-α1 interface.
Che Has AT; Absalom N; van Nieuwenhuijzen PS; Clarkson AN; Ahring PK; Chebib M
Sci Rep; 2016 Jun; 6():28674. PubMed ID: 27346730
[TBL] [Abstract][Full Text] [Related]
44. Discriminative stimulus effects of benzodiazepine (BZ)(1) receptor-selective ligands in rhesus monkeys.
McMahon LR; Gerak LR; Carter L; Ma C; Cook JM; France CP
J Pharmacol Exp Ther; 2002 Feb; 300(2):505-12. PubMed ID: 11805210
[TBL] [Abstract][Full Text] [Related]
45. Quantitative evaluation of benzodiazepine receptors in live Papio papio baboons using positron emission tomography.
Brouillet E; Chavoix C; Khalili-Varasteh M; Bottlaender M; Hantraye P; Yorke JC; Maziere M
Mol Pharmacol; 1990 Oct; 38(4):445-50. PubMed ID: 2172764
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and in vivo evaluation of [11C]zolpidem, an imidazopyridine with agonist properties at central benzodiazepine receptors.
Dumont F; Waterhouse RN; Montoya JA; Mattner F; Katsifis A; Kegeles LS; Laruelle M
Nucl Med Biol; 2003 May; 30(4):435-9. PubMed ID: 12767401
[TBL] [Abstract][Full Text] [Related]
47. Status epilepticus induced by pentylenetetrazole modulates in vivo [11C]Ro 15-1788 binding to benzodiazepine receptors. Effects of ligands acting at the supramolecular receptor complex.
Chavoix C; Hantraye P; Brouillet E; Guibert B; Fukuda H; De la Sayette V; Fournier D; Naquet R; Mazière M
Eur J Pharmacol; 1988 Feb; 146(2-3):207-14. PubMed ID: 2836206
[TBL] [Abstract][Full Text] [Related]
48. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
[TBL] [Abstract][Full Text] [Related]
49. Regional changes in [3H]zolpidem binding to brain benzodiazepine receptors in flurazepam tolerant rat: comparison with changes in [3H]flunitrazepam binding.
Wu Y; Rosenberg HC; Chiu TH; Ramsey-Williams V
J Pharmacol Exp Ther; 1994 Feb; 268(2):675-82. PubMed ID: 8113978
[TBL] [Abstract][Full Text] [Related]
50. Zolpidem modulates GABA(A) receptor function in subthalamic nucleus.
Chen L; Xie JX; Fung KS; Yung WH
Neurosci Res; 2007 May; 58(1):77-85. PubMed ID: 17337310
[TBL] [Abstract][Full Text] [Related]
51. Status epilepticus alters zolpidem sensitivity of [3H]flunitrazepam binding in the developing rat brain.
Laurén HB; Lopez-Picon FR; Kukko-Lukjanov TK; Uusi-Oukari M; Holopainen IE
Neuroscience; 2007 May; 146(2):802-11. PubMed ID: 17360122
[TBL] [Abstract][Full Text] [Related]
52. Discriminative stimulus effects of zolpidem in squirrel monkeys: comparison with conventional benzodiazepines and sedative-hypnotics.
Rowlett JK; Spealman RD; Lelas S
J Pharmacol Exp Ther; 1999 Dec; 291(3):1233-41. PubMed ID: 10565847
[TBL] [Abstract][Full Text] [Related]
53. Central type benzodiazepine binding sites: a positron emission tomography study in the baboon's brain.
Hantraye P; Kaijima M; Prenant C; Guibert B; Sastre J; Crouzel M; Naquet R; Comar D; Maziere M
Neurosci Lett; 1984 Jul; 48(2):115-20. PubMed ID: 6090993
[TBL] [Abstract][Full Text] [Related]
54. Interaction of suriclone with central type benzodiazepine receptors in living baboons.
Brouillet E; Chavoix C; Hantraye P; Kunimoto M; Khalili-Varasteh M; Chevalier P; Frydman A; Gaillot J; Prenant C; Crouzel M
Eur J Pharmacol; 1990 Jan; 175(1):49-55. PubMed ID: 1969798
[TBL] [Abstract][Full Text] [Related]
55. Discriminative stimulus properties of GABAA receptor positive allosteric modulators TPA023, ocinaplon and NG2-73 in rats trained to discriminate chlordiazepoxide or zolpidem.
Vinkers CH; Olivier B; Hanania T; Min W; Schreiber R; Hopkins SC; Campbell U; Paterson N
Eur J Pharmacol; 2011 Oct; 668(1-2):190-3. PubMed ID: 21762686
[TBL] [Abstract][Full Text] [Related]
56. Dose-dependent EEG effects of zolpidem provide evidence for GABA(A) receptor subtype selectivity in vivo.
Visser SA; Wolters FL; van der Graaf PH; Peletier LA; Danhof M
J Pharmacol Exp Ther; 2003 Mar; 304(3):1251-7. PubMed ID: 12604703
[TBL] [Abstract][Full Text] [Related]
57. [A specific domain (the omega 1 site) of the GABA(A) receptor may be implicated in the hypnotic effects of zolpidem].
Benavides J; Depoortere H; Sanger D; Perrault G; Arbilla S; Langer SZ; Zivkovic B; Scatton B
Encephale; 1990; 16(1):13-22. PubMed ID: 2158421
[TBL] [Abstract][Full Text] [Related]
58. Acute zolpidem administration produces pharmacodynamic and receptor occupancy changes at similar doses.
Fahey JM; Grassi JM; Reddi JM; Greenblatt DJ
Pharmacol Biochem Behav; 2006 Jan; 83(1):21-7. PubMed ID: 16439007
[TBL] [Abstract][Full Text] [Related]
59. Zolpidem binding sites on the GABA(A) receptor in brain from human cirrhotic and non-cirrhotic alcoholics.
Lewohl JM; Crane DI; Dodd PR
Eur J Pharmacol; 1997 May; 326(2-3):265-72. PubMed ID: 9196280
[TBL] [Abstract][Full Text] [Related]
60. Pharmacological characteristics of zolpidem-induced catalepsy in the rat.
Mierzejewski P; Kolaczkowski M; Nowak N; Korkosz A; Scinska A; Sienkiewicz-Jarosz H; Samochowiec J; Kostowski W; Bienkowski P
Neurosci Lett; 2013 Nov; 556():99-103. PubMed ID: 24135337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
